Concurrent treatment with both oleuropein and cisplatin could lead to a more effective chemotherapeutic combination against HCC compared with oleuropein or cisplatin alone, attributed to the influence of oleuropein on the pro-NGF/NGF balance via affecting MMP-7 activity without altering the gene expression of NGF [37]. This evidence concerns the gene NGF and hepatocellular carcinoma.